AI Article Synopsis
- Cigarette smoke is the leading preventable cause of chronic obstructive pulmonary disease (COPD) and smoking cessation can improve respiratory and metabolic health.
- A study assessed current smokers' respiratory functions and metabolic changes after one month of quitting using various tests and methods, including spirometry and blood samples.
- Results showed significant improvements in lung function, reduced exhaled carbon monoxide levels, increased vitamin D, and lower cholesterol after one month of smoking cessation, highlighting the benefits of quitting.
Article Abstract
Background: Cigarette smoke exposure is the main preventable cause of chronic obstructive pulmonary disease (COPD). Airflow limitation is closely associated with smoking exposure. Smoking could also interfere with lipid metabolism.
Aim: To determine the respiratory functional and metabolic changes after smoking cessation in smokers in the short term.
Methods: All patients were current smokers. They were assessed by spirometry and questionnaires such as COPD assessment test(CAT), modified Medical Research Council (mMRC) test for dyspnea, Fagestrom's test for nicotine dependence. Exhaled CO was detected in order to evaluate smoking exposure and smoking cessation (normal value<7 ppm). A blood sampling was eventually taken for vitamin D and cholesterol assay. All patients underwent therapy with counselling and varenicline as first-line treatment according to its schedule. Detection time: at baseline and one month after smoking cessation.
Results: All patients quit smoking during treatment. The mean age was 62 with a prevalence of males. The analysis revealed the following mean values at baseline: CAT mean score was 15, pack-years 35.5, Fagestrom's Test mean score 5.0. The West's value was 8.5, whereas Body mass index (BMI) was 25.5.Cigarette daily consumption mean value was 22.5. The comparison before and at follow up one month after smoking cessation about functional and metabolic parameters, show us the following results: FEV 1 was increased by 200 mL (p<0.02), FEF 25/75 was improved as well as mMRC test. The eCO was dropped to as low as 8 ppM. Interestingly the vitamin D level was increased from 25 to 28 ng/mL without any support therapy. The cholesterol total level was reduced and CAT value and DLCO were also significantly improved.
Conclusion: Quit smoking is useful to improve symptoms, respiratory function and metabolic parameters in the short term.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697086 | PMC |
| http://dx.doi.org/10.2147/COPD.S423148 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Optimal Pathways to Lung Cancer Screening in Primary Care Settings: A Scoping Review.
Curr Oncol
December 2024
Department of Social Medicine, School of Medicine, University of Crete, 71500 Heraklion, Greece.
Lung cancer is the leading cause of cancer-related deaths worldwide, and delayed detection contributes to poor outcomes. Primary care plays a crucial role in early diagnosis, but detecting lung cancer early remains challenging for general practitioners (GPs). Therefore, the aim of this scoping review was to identify optimal strategies and pathways for lung cancer screening (LCS) in primary care settings globally.
View Article and Find Full Text PDFThe Connection Between Stress and Women's Smoking During the Perinatal Period: A Systematic Review.
Brain Sci
December 2024
Department of Clinical Psychology and Psychobiology, Faculty of Psychology, Institute of Psychology (IPsiUS), University of Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain.
Introduction: In women, smoking during pregnancy and the postpartum period has important consequences for maternal and infant health, and interventions to assist smoking cessation during this period are essential. Although smoking has been associated with the presence of mental health problems, few studies addressing the factors associated with perinatal smoking have examined the role of stress. The aim of this review was to identify the relationships between the presence of stress and smoking during pregnancy and the postpartum period.
View Article and Find Full Text PDFInvestigating Risk Factors for Racial Disparity in E-Cigarette Use with PATH Study.
Stats (Basel)
September 2024
Biostatistics and Data Sciences, Louisiana State University Health Sciences Center School of Public Health, New Orleans, LA 70122, USA.
Background: Previous research has identified differences in e-cigarette use and socioeconomic factors between different racial groups However, there is little research examining specific risk factors contributing to the racial differences.
Objective: This study sought to identify racial disparities in e-cigarette use and to determine risk factors that help explain these differences.
Methods: We used Wave 5 (2018-2019) of the Adult Population Assessment of Tobacco and Health (PATH) Study.
Implementation of stop smoking support by mental healthcare professionals: cross-sectional analysis of why nothing much happens.
Discov Ment Health
January 2025
Public Health and Primary Care, Leiden University Medical Center, Hippocratespad 21, PO Box 9600, 2300 RC, Leiden, The Netherlands.
Smoking is highly prevalent and persistent among people with mental illness, but implementation of smoking cessation care by mental healthcare professionals (MHCPs) is lagging behind. This study took a broad approach to understanding implementation of stop smoking support (SSS) by MHCPs (N = 220 for main analyses), incorporating background characteristics, psychosocial factors, client factors, and organizational/environmental factors. Variable selection was based on previous work and the Consolidated Framework for Implementation Research.
View Article and Find Full Text PDFSupport for and likely impacts of endgame measures in the Smokefree Aotearoa Action Plan: findings from the 2020-2021 International Tobacco Control New Zealand (EASE) surveys.
N Z Med J
January 2025
Professor, Department of Public Health, University of Otago Wellington, Wellington.
Aim: In February 2024, the Aotearoa New Zealand Government repealed legislation to mandate very low nicotine cigarettes (VLNCs), greatly reduce the number of tobacco retailers and disallow sale of tobacco products to people born after 2008 (smokefree generation). We investigated acceptability and likely impacts of these measures among people who smoke or who recently (≤2 years) quit smoking.
Method: We analysed data from 1,230 participants from Wave 3 (conducted in late 2020 and early 2021) and 615 participants from Wave 3.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!